A non-catalytic function for Rad18 in sustaining glioblastoma proliferation
Nour El Houda Benbahouche, Antoine Aze, Aurore SiegfriediD, Lenka ŠtefančíkováiD, Chames KermiiD, Jean‐Marc PascussiiD, Julie PannequiniD, Jérôme MoreauxiD, Tom EggeriD, Alain ChavanieuiD, Jean‐Philippe HugnotiD, Marie‐Bernadette DelisleiD, Elizabeth Cohen‐Jonathan MoyaliD, Emmanuelle Uro‐CosteiD, Domenico MaioranoiD
Abstract
The Rad18 E3 ubiquitin ligase, a non-essential gene, is a key regulator of DNA damage tolerance that also functions in repair of DNA double strand breaks. Rad18 is overexpressed in the aggressive brain cancer glioblastoma (GBM) and its downregulation sensitizes glioblastoma cells to DNA damaging agents. Here we show that Rad18 has an essential role in GBM cells proliferation in the absence of external damage, surprisingly independent of its catalytic activity. Rad18 downregulation leads to cell cycle arrest in the G1 phase in the absence of apparent DNA damage. We also show that Rad18 sustains GBM stem cells self-renewal and survival, as well as the growth of tumor orthotropic xenografts in mice. We also show that increased Rad18 expression enhances the growth of non-transformed cells and induces features of oncogenic transformation. Mechanistically, we show that Rad18 downregulation negatively regulates the Hippo pathway by interfering with the nuclear retention of the YAP1 transcription factor. Altogether, these data show that Rad18 has an essential, non-catalytic function, in GBM proliferation, and propose Rad18 as a key target to sensitize GBM to therapy.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 45th percentile
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in Glioblastoma
- BRAT1 - a new therapeutic target for glioblastoma
Alicia Haydo, Jennifer Schmidt, … Benedikt Linder·Cellular and Molecular Life SciencesPeer-reviewed·Jan 20, 2025
- HAUSP Stabilizes SOX2 through Deubiquitination to Maintain Self-renewal and Tumorigenic Potential of Glioma Stem Cells
- IDH1R132H acts as a tumor suppressor in glioma via epigenetic upregulation of the DNA damage response
Felipe J. Núñez, Flor M. Mendez, … Maria G. Castro·bioRxiv·Aug 10, 2018
- Collagen-dependent DDR1 ectodomain shedding regulates proliferative signaling in radiation-resistant glioblastoma
Sophia Dunlap, Caitlin A. Harvey, … Eun-Young Erin Ahn·bioRxiv·Oct 9, 2026
- SOX21 Suppresses Glioblastoma Growth by Repressing AP-1 Activity
Eltjona Rrapaj, Juan Yuan, … Jonas Muhr·Cell Death and DiseasePeer-reviewed·Jan 31, 2026